• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛磺胆酸是一种活性促进因子,而非仅仅是肝硬化进展的生物标志物:来自一项人体代谢组学研究和体外实验的证据。

Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments.

作者信息

Liu Zhimin, Zhang Zhifeng, Huang Mei, Sun Xiaoping, Liu Bojia, Guo Qiyang, Chang Qingshan, Duan Zhijun

机构信息

Second department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.

The Sixth People's Hospital of Dalian, Dalian, 116021, China.

出版信息

BMC Gastroenterol. 2018 Jul 11;18(1):112. doi: 10.1186/s12876-018-0842-7.

DOI:10.1186/s12876-018-0842-7
PMID:29996772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6042259/
Abstract

BACKGROUND

Previous studies have indicated that bile acid is associated with progression of liver cirrhosis. However, the particular role of specific bile acid in the development of liver cirrhosis is not definite. The present study aims to identify the specific bile acid and explore its possible mechanisms in promoting liver cirrhosis.

METHODS

Thirty two cirrhotic patients and 27 healthy volunteers were enrolled. Age, gender, Child-Pugh classification and serum of patients and volunteers were collected. Liquid chromatography tandem mass spectrometry (LC-MS) was utilized to determine concentrations of 12 bile acids in serum. Principal component analysis, fold change analysis and heatmap analysis were used to identify the most changed bile acid. And pathway analysis was used to identify the most affected pathway in bile acid metabolism. Spearman rank correlation analysis was employed to assess correlation between concentrations of bile acids and Child-Pugh classification. Hepatic stellate cells (LX-2) were cultured in DMEM. LX-2 cells were also co-cultured with HepG2 cells in the transwell chambers. LX-2 cells were treated with Na+/taurocholate in different concentrations. Western blot was used to evaluate the expression of alpha smooth muscle actin (α-SMA), type I collagen, and Toll-like receptor 4 (TLR4) in LX-2 cells.

RESULTS

Concentrations of 12 bile acids in serum of patients and healthy volunteers were determined with LC-MS successively. Principal component analysis, fold change analysis and heatmap analysis identified taurocholic acid (TCA) to be the most changed bile acid. Pathway analysis showed that TCA biosynthesis increased significantly. Spearman rank correlation analysis showed that concentration of TCA in serum of cirrhotic patients was positively associated with Child-Pugh classification. TCA increased the expression of α-SMA, type I collagen, and TLR4 in LX-2 cells. Moreover, the above effect was strengthened when LX-2 cells were co-cultured with HepG2 cells.

CONCLUSIONS

Increased TCA concentration in serum of liver cirrhotic patients is mainly due to increased bile acid biosynthesis. TCA is an active promoter of the progression of liver cirrhosis. TCA promoting liver cirrhosis is likely through activating hepatic stellate cells via upregulating TLR4 expression. TCA is a potential therapeutic target for the prevention and treatment of liver cirrhosis.

摘要

背景

既往研究表明胆汁酸与肝硬化进展相关。然而,特定胆汁酸在肝硬化发展中的具体作用尚不明确。本研究旨在鉴定特定胆汁酸,并探讨其促进肝硬化的可能机制。

方法

纳入32例肝硬化患者和27名健康志愿者。收集患者和志愿者的年龄、性别、Child-Pugh分级及血清。采用液相色谱串联质谱法(LC-MS)测定血清中12种胆汁酸的浓度。运用主成分分析、倍数变化分析和热图分析来鉴定变化最大的胆汁酸。并通过通路分析来鉴定胆汁酸代谢中受影响最大的通路。采用Spearman秩相关分析评估胆汁酸浓度与Child-Pugh分级之间的相关性。肝星状细胞(LX-2)在DMEM中培养。LX-2细胞也在Transwell小室中与HepG2细胞共培养。用不同浓度的牛磺胆酸钠处理LX-2细胞。采用蛋白质免疫印迹法评估LX-2细胞中α平滑肌肌动蛋白(α-SMA)、I型胶原蛋白和Toll样受体4(TLR4)的表达。

结果

先后用LC-MS测定了患者和健康志愿者血清中12种胆汁酸的浓度。主成分分析、倍数变化分析和热图分析确定牛磺胆酸(TCA)是变化最大的胆汁酸。通路分析表明TCA生物合成显著增加。Spearman秩相关分析显示,肝硬化患者血清中TCA浓度与Child-Pugh分级呈正相关。TCA增加了LX-2细胞中α-SMA、I型胶原蛋白和TLR4的表达。此外,当LX-2细胞与HepG2细胞共培养时,上述作用增强。

结论

肝硬化患者血清中TCA浓度升高主要是由于胆汁酸生物合成增加。TCA是肝硬化进展的活跃促进因子。TCA促进肝硬化可能是通过上调TLR4表达激活肝星状细胞。TCA是预防和治疗肝硬化的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/6042259/51a44794327e/12876_2018_842_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/6042259/8a2f564c1837/12876_2018_842_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/6042259/e9f82968c057/12876_2018_842_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/6042259/51a44794327e/12876_2018_842_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/6042259/8a2f564c1837/12876_2018_842_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/6042259/e9f82968c057/12876_2018_842_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/6042259/51a44794327e/12876_2018_842_Fig3_HTML.jpg

相似文献

1
Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments.牛磺胆酸是一种活性促进因子,而非仅仅是肝硬化进展的生物标志物:来自一项人体代谢组学研究和体外实验的证据。
BMC Gastroenterol. 2018 Jul 11;18(1):112. doi: 10.1186/s12876-018-0842-7.
2
Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.血清胆汁酸与乙型肝炎所致肝硬化的病理进展相关。
J Proteome Res. 2016 Apr 1;15(4):1126-34. doi: 10.1021/acs.jproteome.5b00217. Epub 2016 Mar 22.
3
Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2.乙型肝炎病毒X蛋白促进人肝星状细胞系LX-2的增殖,并上调转化生长因子-β1和结缔组织生长因子。
Hepatobiliary Pancreat Dis Int. 2009 Feb;8(1):59-64.
4
Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation.北柴胡中的柴胡皂甙 A 在肝星状细胞激活过程中升高骨形态发生蛋白 4(BMP-4)。
Phytomedicine. 2013 Nov 15;20(14):1330-5. doi: 10.1016/j.phymed.2013.07.010. Epub 2013 Aug 19.
5
A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses.A20减轻非酒精性脂肪性肝病中的肝纤维化并抑制炎症反应。
Inflammation. 2017 Jun;40(3):840-848. doi: 10.1007/s10753-017-0528-2.
6
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD.肝组织 Toll 样受体 4 的表达与非酒精性脂肪性肝病患者的门脉炎症和纤维化相关。
Liver Int. 2015 Feb;35(2):569-81. doi: 10.1111/liv.12531. Epub 2014 Apr 5.
7
Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.黄芪汤减轻二甲基亚硝胺诱导的肝纤维化:胆汁酸代谢机制分析
J Ethnopharmacol. 2016 Aug 2;189:148-56. doi: 10.1016/j.jep.2016.05.040. Epub 2016 May 16.
8
CC motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells.CC 基序趋化因子配体 16 通过使肝星状细胞失活来抑制肝纤维化的进展。
Hepatobiliary Pancreat Dis Int. 2020 Oct;19(5):440-448. doi: 10.1016/j.hbpd.2019.12.006. Epub 2020 Jan 3.
9
Metabolic profiling of endogenous bile acids: a novel method to assess hepatoprotective effect of Tanreqing capsule on carbon-tetrachloride-induced liver injury in rats.内源性胆汁酸代谢组学:评估丹参酮胶囊对四氯化碳诱导的大鼠肝损伤保护作用的新方法。
Chin J Nat Med. 2018 Apr;16(4):271-283. doi: 10.1016/S1875-5364(18)30057-8.
10
Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.牛磺胆酸在胆汁淤积条件下通过 S1PR2/p38 MAPK/YAP 信号促进肝星状细胞激活。
Clin Mol Hepatol. 2023 Apr;29(2):465-481. doi: 10.3350/cmh.2022.0327. Epub 2023 Feb 20.

引用本文的文献

1
The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy.微生物群在非酒精性脂肪性肝病中的作用:作用机制与治疗策略。
Front Microbiol. 2025 Jul 30;16:1621583. doi: 10.3389/fmicb.2025.1621583. eCollection 2025.
2
Metabolomic profiles in serum uncover novel biomarkers in children with Williams-Beuren syndrome.血清代谢组学图谱揭示威廉姆斯-贝伦综合征患儿的新型生物标志物。
Sci Rep. 2025 Mar 19;15(1):9437. doi: 10.1038/s41598-025-94018-w.
3
Bile acid receptors and signaling crosstalk in the liver, gut and brain.

本文引用的文献

1
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.胆汁酸-微生物群互作对胃肠道炎症和癌变的影响。
Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128. doi: 10.1038/nrgastro.2017.119. Epub 2017 Oct 11.
2
The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice.未折叠蛋白反应通过调节小鼠中的TANGO1介导纤维化和I型胶原蛋白分泌。
Hepatology. 2017 Mar;65(3):983-998. doi: 10.1002/hep.28921. Epub 2016 Dec 31.
3
Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis.
肝脏、肠道和大脑中的胆汁酸受体与信号转导串扰
Liver Res. 2021 Jul 18;5(3):105-118. doi: 10.1016/j.livres.2021.07.002. eCollection 2021 Sep.
4
Bile Acid Composition and Transcriptome Analysis of the Liver and Small Intestine in Different Species.不同物种肝脏和小肠的胆汁酸组成及转录组分析
Metabolites. 2024 Aug 15;14(8):451. doi: 10.3390/metabo14080451.
5
Sex-specific effects of gut microbiome on shaping bile acid metabolism.肠道微生物群对胆汁酸代谢塑造的性别特异性影响。
bioRxiv. 2024 Jun 27:2024.06.27.601003. doi: 10.1101/2024.06.27.601003.
6
Longitudinal metabolomics of human plasma reveal metabolic dynamics and predictive markers of antituberculosis drug-induced liver injury.人类血浆的纵向代谢组学揭示了抗结核药物性肝损伤的代谢动态和预测标志物。
Respir Res. 2024 Jun 21;25(1):254. doi: 10.1186/s12931-024-02837-8.
7
The anticancer activity of bile acids in drug discovery and development.胆汁酸在药物研发中的抗癌活性。
Front Pharmacol. 2024 Feb 20;15:1362382. doi: 10.3389/fphar.2024.1362382. eCollection 2024.
8
Low sphingolipid levels predict poor survival in patients with alcohol-related liver disease.鞘脂水平低预示着酒精性肝病患者的生存状况不佳。
JHEP Rep. 2023 Nov 1;6(2):100953. doi: 10.1016/j.jhepr.2023.100953. eCollection 2024 Feb.
9
The contributions of bacteria metabolites to the development of hepatic encephalopathy.细菌代谢产物对肝性脑病发展的作用。
Liver Res. 2023 Dec;7(4):296-303. doi: 10.1016/j.livres.2022.11.005. Epub 2022 Nov 15.
10
Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid.SLC27A5 缺失通过非结合胆酸激活肝星状细胞并促进肝纤维化。
Adv Sci (Weinh). 2024 Jan;11(2):e2304408. doi: 10.1002/advs.202304408. Epub 2023 Nov 13.
使用MetaboAnalyst 3.0进行综合代谢组学数据分析。
Curr Protoc Bioinformatics. 2016 Sep 7;55:14.10.1-14.10.91. doi: 10.1002/cpbi.11.
4
Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.血清胆汁酸作为非胆汁淤积性肝硬化患者急性失代偿和慢加急性肝衰竭的标志物。
Liver Int. 2017 Feb;37(2):224-231. doi: 10.1111/liv.13201. Epub 2016 Aug 4.
5
Serum Metabolomic Profiling in a Rat Model Reveals Protective Function of Paeoniflorin Against ANIT Induced Cholestasis.大鼠模型中的血清代谢组学分析揭示了芍药苷对ANIT诱导的胆汁淤积的保护作用。
Phytother Res. 2016 Apr;30(4):654-62. doi: 10.1002/ptr.5575. Epub 2016 Jan 25.
6
An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.一项关于乙型肝炎病毒的流行病学血清学调查显示,由于在中国中部地区进行了乙肝疫苗接种,其流行率有下降的迹象。
Int J Infect Dis. 2015 Nov;40:75-80. doi: 10.1016/j.ijid.2015.10.002. Epub 2015 Oct 9.
7
Primary biliary cirrhosis.原发性胆汁性肝硬化。
Lancet. 2015 Oct 17;386(10003):1565-75. doi: 10.1016/S0140-6736(15)00154-3. Epub 2015 Sep 11.
8
Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.2001-2013 年美国退伍军人中潜在肝脏疾病导致的肝硬化和肝细胞癌负担趋势。
Gastroenterology. 2015 Nov;149(6):1471-1482.e5; quiz e17-8. doi: 10.1053/j.gastro.2015.07.056. Epub 2015 Aug 5.
9
Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.血清胆汁酸与乙型肝炎所致肝硬化的病理进展相关。
J Proteome Res. 2016 Apr 1;15(4):1126-34. doi: 10.1021/acs.jproteome.5b00217. Epub 2016 Mar 22.
10
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.1980年至2010年间187个国家的肝硬化死亡率:一项系统分析。
BMC Med. 2014 Sep 18;12:145. doi: 10.1186/s12916-014-0145-y.